FloTrac／Vigileo在休克患者液体治疗中的有效性研究

The effectiveness of FloTrac/Vigileo in fluid therapy for ICU patients with shock

目的评估FloTrac／Vigileo在休克患者液体治疗中的有效性。方法根据是否使用FloTrac／Vigileo将ICU的休克患者分为FloTrac／Vigileo监测治疗组（简称Vigileo组）和常规治疗组，比较两组患者基本资料、临床治疗指标和预后。结果共计纳入研究分析患者170例，其中Vigileo组74例，常规治疗组96例。治疗后8h，Vigileo组治疗有效率为85．14％，常规治疗组为51．04％，差异有统计学意义（P〈0．05）；Vigileo组ICU病死率为20．27％，常规治疗组为37．5％，差异有统计学意义（P〈0．05）；Vigileo组住院病死率为37．8％，常规治疗组为40．6％，差异无统计学意义（P〉0．05）。结论Flo Trac／Vigileo能有效指导休克患者的液体治疗，提高治疗有效率，降低ICU病死率。

Objective To investigate the effectiveness of FloTrac/Vigileo in fluid therapy for ICU patients with shock. Methods ICU patients with shock were divided into vigileo group and the routine treatment group by using FloTrac/ Vigileo or not. Demographic data, clinical variables and outcomes were compared. Results A total of 170 patients were contained, including 74 patients in vigileo group and 96 patients in the routine treatment group. Eight hours after treatment, effective rate of vigileo group was higher compared with the routine treatment group （P〈0.05）. ICU mortality of vigileo group was lower compared with the routine treatment group（P〈0.05）. There was no statistical difference in hospital mortality between groups （P〉0.05）. Conclusions Fluidtherapy could be effectively guided by FloTrac/Vigileo in ICU patients with shock, and thus effective rate was improved and ICU mortality was decreased.